Lactoferrin (LF), as a multifunctional ... protein to the cell membrane’s surface to promote glucose translocation, all of which have a positive impact on the state of insulin-resistant glucose ...

A drug candidate, previously successful at treating severe fatty liver disease, reduces atherosclerosis—a primary driver of ...

A drug candidate, previously successful at treating severe fatty liver disease, reduces atherosclerosis - a primary driver of cardiovascular death worldwide - in large mammals, a study suggests.

Citation: Preventing harmful protein aggregation: Synthetic peptides as the basis for multifunctional drugs in Parkinson's disease (2025, April 24) retrieved 28 April 2025 from https://phys.org ...

A drug candidate, previously successful at treating severe fatty liver disease, reduces atherosclerosis — a primary driver ... part by reducing signaling from the NLRP3 “inflammasome” protein, which ...

In a twist that complicates the future of treatment for severe liver disease, scientists have discovered that blocking a key inflammatory protein in the liver may save one organ while damaging others.

In Alzheimer's, Parkinson's, and type 2 diabetes, harmful protein aggregates and deposits, known as amyloid plaques, develop. There is also much evidence that these three diseases are ...